Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Amortizatization of Intangibles (2016 - 2021)

Historic Amortizatization of Intangibles for Neurocrine Biosciences (NBIX) over the last 12 years, with Q4 2021 value amounting to $4.1 million.

  • Neurocrine Biosciences' Amortizatization of Intangibles fell 1458.33% to $4.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was $16.2 million, marking a year-over-year decrease of 1900.0%. This contributed to the annual value of $26.2 million for FY2024, which is 4316.94% up from last year.
  • Per Neurocrine Biosciences' latest filing, its Amortizatization of Intangibles stood at $4.1 million for Q4 2021, which was down 1458.33% from $4.2 million recorded in Q3 2021.
  • In the past 5 years, Neurocrine Biosciences' Amortizatization of Intangibles ranged from a high of $5.2 million in Q3 2020 and a low of -$269000.0 during Q1 2017
  • Its 5-year average for Amortizatization of Intangibles is $4.2 million, with a median of $4.4 million in 2018.
  • In the last 5 years, Neurocrine Biosciences' Amortizatization of Intangibles soared by 168550.19% in 2018 and then tumbled by 2200.0% in 2021.
  • Quarter analysis of 5 years shows Neurocrine Biosciences' Amortizatization of Intangibles stood at $4.2 million in 2017, then rose by 9.04% to $4.6 million in 2018, then increased by 5.26% to $4.8 million in 2019, then changed by 0.0% to $4.8 million in 2020, then decreased by 14.58% to $4.1 million in 2021.
  • Its Amortizatization of Intangibles was $4.1 million in Q4 2021, compared to $4.2 million in Q3 2021 and $4.0 million in Q2 2021.